UW23077
OPEN TO ACCRUAL
Correlating Early FDG PET/CT and ctDNA in ICI-Treated Melanoma Patients
UW25072
OPEN TO ACCRUAL
Phase 1b/2 Trial of Hepzato Kit & Opdualag for Metastatic Melanoma and Liver Metastasis
UW24061
OPEN TO ACCRUAL
Ph 3 Study w/Combo of Fianlimab+Cemiplimab vs Relatlimab+Nivo in Participants w/Metastatic Melanoma
UW24110
OPEN TO ACCRUAL
Ph2/3 Open-label RP2 w/ Nivolumab vs Ipilimumab w/ Nivolumab in pts w Mets Uveal Melanoma
UW25011
OPEN TO ACCRUAL
Phase 1 Study of PF-07799544 as Monotherapy or combo in Participants w/ BRAF-Mutant Melanoma
UW18132
OPEN TO ACCRUAL
Evaluation of Circulating Tumor Cells in Melanoma
UW21049
OPEN TO ACCRUAL
PII Hypofractionated VS conventional fractionated RT in soft tissue sarcomas
UW23071
OPEN TO ACCRUAL
AU-011-301